Similarly, in a cohort of 94 patients with endometrial cancer, L1CAM expression was of prognostic value only in the non-specific molecular profile subgroup, and in these patients, its expression was associated with early relapse after platinum-based chemotherapy [61]. The gene discussed is L1CAM; the disease is endometrial cancer.